InflaRx NV (IFRX)
1.61
+0.16
(+11.03%)
USD |
NASDAQ |
May 17, 16:00
1.61
0.00 (0.00%)
After-Hours: 19:33
InflaRx Enterprise Value: -5.240M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | -5.240M |
| May 15, 2024 | -8.184M |
| May 14, 2024 | -6.418M |
| May 13, 2024 | -17.02M |
| May 10, 2024 | -21.14M |
| May 09, 2024 | -19.96M |
| May 08, 2024 | -19.96M |
| May 07, 2024 | -17.61M |
| May 06, 2024 | -14.37M |
| May 03, 2024 | -9.362M |
| May 02, 2024 | -9.362M |
| May 01, 2024 | -7.595M |
| April 30, 2024 | -9.951M |
| April 29, 2024 | -8.773M |
| April 26, 2024 | -12.31M |
| April 25, 2024 | -8.773M |
| April 24, 2024 | -10.54M |
| April 23, 2024 | -10.54M |
| April 22, 2024 | -9.951M |
| April 19, 2024 | -11.13M |
| April 18, 2024 | -16.43M |
| April 17, 2024 | -16.13M |
| April 16, 2024 | -13.48M |
| April 15, 2024 | -8.773M |
| April 12, 2024 | -2.296M |
| Date | Value |
|---|---|
| April 11, 2024 | 0.0594M |
| April 10, 2024 | -1.118M |
| April 09, 2024 | 4.770M |
| April 08, 2024 | -1.118M |
| April 05, 2024 | 0.6483M |
| April 04, 2024 | 1.237M |
| April 03, 2024 | 0.6483M |
| April 02, 2024 | 0.0594M |
| April 01, 2024 | -1.118M |
| March 31, 2024 | 0.0594M |
| March 28, 2024 | -9.107M |
| March 27, 2024 | -9.107M |
| March 26, 2024 | -9.107M |
| March 25, 2024 | -9.107M |
| March 22, 2024 | -12.05M |
| March 21, 2024 | -9.107M |
| March 20, 2024 | -0.2744M |
| March 19, 2024 | -0.2744M |
| March 18, 2024 | -11.46M |
| March 15, 2024 | -6.752M |
| March 14, 2024 | -10.28M |
| March 13, 2024 | -6.752M |
| March 12, 2024 | -7.340M |
| March 11, 2024 | -4.396M |
| March 08, 2024 | -4.396M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-92.22M
Minimum
Sep 27 2019
876.18M
Maximum
May 21 2019
19.68M
Average
2.739M
Median
Enterprise Value Benchmarks
| Affimed NV | 15.69M |
| MorphoSys AG | 2.852B |
| BioNTech SE | 5.744B |
| Immatics NV | 505.00M |
| CureVac NV | 332.77M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.49M |
| Revenue (Quarterly) | 0.0391M |
| Total Expenses (Quarterly) | 13.60M |
| EPS Diluted (Quarterly) | -0.1847 |
| Gross Profit Margin (Quarterly) | -511.9% |
| Profit Margin (Quarterly) | -26.80K% |
| Earnings Yield | -48.47% |